aluates Reports

$ 0.0

Automative

Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-31B1896

Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Insights Forecast to 2028

BUY CHAPTERS

Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Research Report 2025

Code: QYRE-Auto-31B1896

Report

July 2025

Pages:69

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Infervision

BlueDot

Yitu Healthcare

SPHCC

AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size

In order to maintain its leading position, the United States will increase its investment in artificial intelligence research and development in non-defense fields, from US$1.6 billion to US$1.7 billion in 2022.

AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market

The global market for AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

As an important force driving a new round of scientific and technological revolution, artificial intelligence has been of national strategic importance. Many governments introduces polices and increase capital investment to support AI companies. The Digital Europe plan adopted by the European Union will allocate €9.2 billion on high-tech investments, such as supercomputing, artificial intelligence, and network security. According to the latest data released by IDC, global artificial intelligence revenue was US$432.8 billion in 2022, a year-on-year increase of 19.91%, including software, hardware and services.

This report aims to provide a comprehensive presentation of the global market for AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia.

The AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Report

Report Metric	Details
Report Name	AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market
Accounted market size in 2022	US$ billion to US$ 1.7 billion
Base Year	2022
Segment by Type	Pre-Outbreak Forecast CT Diagnosis Other
Segment by Application	Hospital Center for Infectious Diseases Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Infervision, BlueDot, Yitu Healthcare, SPHCC
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market report?

Ans: The main players in the AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market are Infervision, BlueDot, Yitu Healthcare, SPHCC

What are the Application segmentation covered in the AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market report?

Ans: The Applications covered in the AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market report are Hospital, Center for Infectious Diseases, Other

What are the Type segmentation covered in the AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market report?

Ans: The Types covered in the AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market report are Pre-Outbreak Forecast, CT Diagnosis, Other

Recommended Reports

AI Diagnostics

COVID-19 Detection

Respiratory Disease Treatment

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Pre-Outbreak Forecast

1.2.3 CT Diagnosis

1.2.4 Other

1.3 Market by Application

1.3.1 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Center for Infectious Diseases

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Perspective (2020-2031)

2.2 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Growth Trends by Region

2.2.1 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Historic Market Size by Region (2020-2025)

2.2.3 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecasted Market Size by Region (2026-2031)

2.3 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Dynamics

2.3.1 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Industry Trends

2.3.2 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Drivers

2.3.3 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Challenges

2.3.4 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Players by Revenue

3.1.1 Global Top AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Players by Revenue (2020-2025)

3.1.2 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue Market Share by Players (2020-2025)

3.2 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue

3.4 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Concentration Ratio

3.4.1 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue in 2024

3.5 Global Key Players of AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Head office and Area Served

3.6 Global Key Players of AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia, Product and Application

3.7 Global Key Players of AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Breakdown Data by Type

4.1 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Historic Market Size by Type (2020-2025)

4.2 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecasted Market Size by Type (2026-2031)

5 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Breakdown Data by Application

5.1 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Historic Market Size by Application (2020-2025)

5.2 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size (2020-2031)

6.2 North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2020-2025)

6.4 North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size (2020-2031)

7.2 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2020-2025)

7.4 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size (2020-2031)

8.2 Asia-Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Region (2020-2025)

8.4 Asia-Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size (2020-2031)

9.2 Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2020-2025)

9.4 Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size (2020-2031)

10.2 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2020-2025)

10.4 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Infervision

11.1.1 Infervision Company Details

11.1.2 Infervision Business Overview

11.1.3 Infervision AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Introduction

11.1.4 Infervision Revenue in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Business (2020-2025)

11.1.5 Infervision Recent Development

11.2 BlueDot

11.2.1 BlueDot Company Details

11.2.2 BlueDot Business Overview

11.2.3 BlueDot AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Introduction

11.2.4 BlueDot Revenue in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Business (2020-2025)

11.2.5 BlueDot Recent Development

11.3 Yitu Healthcare

11.3.1 Yitu Healthcare Company Details

11.3.2 Yitu Healthcare Business Overview

11.3.3 Yitu Healthcare AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Introduction

11.3.4 Yitu Healthcare Revenue in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Business (2020-2025)

11.3.5 Yitu Healthcare Recent Development

11.4 SPHCC

11.4.1 SPHCC Company Details

11.4.2 SPHCC Business Overview

11.4.3 SPHCC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Introduction

11.4.4 SPHCC Revenue in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Business (2020-2025)

11.4.5 SPHCC Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Infervision

BlueDot

Yitu Healthcare

SPHCC

List of Tables

Table 1. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Pre-Outbreak Forecast

Table 3. Key Players of CT Diagnosis

Table 4. Key Players of Other

Table 5. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Region (2020-2025)

Table 9. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Region (2026-2031)

Table 11. AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Trends

Table 12. AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Drivers

Table 13. AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Challenges

Table 14. AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Restraints

Table 15. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Players (2020-2025)

Table 17. Global Top AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia as of 2024)

Table 18. Ranking of Global Top AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia, Headquarters and Area Served

Table 21. Global Key Players of AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia, Product and Application

Table 22. Global Key Players of AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue Market Share by Type (2020-2025)

Table 26. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue Market Share by Type (2026-2031)

Table 28. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue Market Share by Application (2020-2025)

Table 30. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue Market Share by Application (2026-2031)

Table 32. North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2026-2031) & (US$ Million)

Table 47. Infervision Company Details

Table 48. Infervision Business Overview

Table 49. Infervision AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Product

Table 50. Infervision Revenue in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Business (2020-2025) & (US$ Million)

Table 51. Infervision Recent Development

Table 52. BlueDot Company Details

Table 53. BlueDot Business Overview

Table 54. BlueDot AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Product

Table 55. BlueDot Revenue in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Business (2020-2025) & (US$ Million)

Table 56. BlueDot Recent Development

Table 57. Yitu Healthcare Company Details

Table 58. Yitu Healthcare Business Overview

Table 59. Yitu Healthcare AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Product

Table 60. Yitu Healthcare Revenue in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Business (2020-2025) & (US$ Million)

Table 61. Yitu Healthcare Recent Development

Table 62. SPHCC Company Details

Table 63. SPHCC Business Overview

Table 64. SPHCC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Product

Table 65. SPHCC Revenue in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Business (2020-2025) & (US$ Million)

Table 66. SPHCC Recent Development

Table 67. Research Programs/Design for This Report

Table 68. Key Data Information from Secondary Sources

Table 69. Key Data Information from Primary Sources

Table 70. Authors List of This Report

List of Figures

Figure 1. AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Picture

Figure 2. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Type: 2024 VS 2031

Figure 4. Pre-Outbreak Forecast Features

Figure 5. CT Diagnosis Features

Figure 6. Other Features

Figure 7. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Application: 2024 VS 2031

Figure 9. Hospital Case Studies

Figure 10. Center for Infectious Diseases Case Studies

Figure 11. Other Case Studies

Figure 12. AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Report Years Considered

Figure 13. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Region: 2024 VS 2031

Figure 16. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Players in 2024

Figure 17. Global Top AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue in 2024

Figure 19. North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Country (2020-2031)

Figure 21. United States AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Country (2020-2031)

Figure 25. Germany AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Region (2020-2031)

Figure 33. China AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Country (2020-2031)

Figure 41. Mexico AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Share by Country (2020-2031)

Figure 45. Turkey AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Infervision Revenue Growth Rate in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Business (2020-2025)

Figure 49. BlueDot Revenue Growth Rate in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Business (2020-2025)

Figure 50. Yitu Healthcare Revenue Growth Rate in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Business (2020-2025)

Figure 51. SPHCC Revenue Growth Rate in AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Business (2020-2025)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350